Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
requiring 17 26 17 26 O
treatment 27 36 27 36 B-treatment
, 36 37 36 37 O
known 38 43 38 43 O
immunosuppressive 44 61 44 61 B-chronic_disease
disease 62 69 62 69 I-chronic_disease
, 69 70 69 70 O
active 71 77 71 77 O
systemic 78 86 78 86 B-chronic_disease
autoimmune 87 97 87 97 I-chronic_disease
diseases 98 106 98 106 I-chronic_disease
such 107 111 107 111 O
as 112 114 112 114 O
lupus 115 120 115 120 B-chronic_disease
, 120 121 120 121 O
receipt 122 129 122 129 O
of 130 132 130 132 O
systemic 133 141 133 141 B-treatment
immunosuppressive 142 159 142 159 I-treatment
therapy 160 167 160 167 I-treatment

Administration 0 14 168 182 O
of 15 17 183 185 O
immunosuppressive 18 35 186 203 B-treatment
drugs 36 41 204 209 I-treatment
less 42 46 210 214 O
than 47 51 215 219 O
2 52 53 220 221 B-upper_bound
weeks 54 59 222 227 I-upper_bound
prior 60 65 228 233 I-upper_bound
to 66 68 234 236 O
first 69 74 237 242 O
dose 75 79 243 247 O
of 80 82 248 250 O
ERC1671 83 90 251 258 B-treatment

Age 0 3 259 262 B-age
≥18 4 7 263 266 O
years 8 13 267 272 I-lower_bound
of 14 16 273 275 O
age 17 20 276 279 B-age

All 0 3 280 283 B-gender
female 4 10 284 290 I-gender
patients 11 19 291 299 I-gender
with 20 24 300 304 O
reproductive 25 37 305 317 O
potential 38 47 318 327 O
must 48 52 328 332 O
have 53 57 333 337 O
a 58 59 338 339 O
negative 60 68 340 348 B-pregnancy
pregnancy 69 78 349 358 I-pregnancy
test 79 83 359 363 O
prior 84 89 364 369 O
to 90 92 370 372 O
Day 93 96 373 376 O
1 97 98 377 378 O

Anticipation 0 12 379 391 O
of 13 15 392 394 O
need 16 20 395 399 O
for 21 24 400 403 O
major 25 30 404 409 B-treatment
surgical 31 39 410 418 I-treatment
procedure 40 49 419 428 O
during 50 56 429 435 O
the 57 60 436 439 O
course 61 67 440 446 O
of 68 70 447 449 O
the 71 74 450 453 O
study 75 80 454 459 O

CD4 0 3 460 463 B-clinical_variable
count 4 9 464 469 I-clinical_variable
> 10 11 470 471 O
450 12 15 472 475 B-lower_bound
/ 15 16 475 476 I-lower_bound
mcL 16 19 476 479 I-lower_bound

Evidence 0 8 480 488 O
of 9 11 489 491 O
recent 12 18 492 498 O
hemorrhage 19 29 499 509 B-chronic_disease
on 30 32 510 512 O
screening 33 42 513 522 O
MRI 43 46 523 526 B-treatment
of 47 49 527 529 O
the 50 53 530 533 O
brain 54 59 534 539 O

First 0 5 540 545 O
or 6 8 546 548 O
second 9 15 549 555 O
relapse 16 23 556 563 O
of 24 26 564 566 O
glioblastoma 27 39 567 579 B-cancer

Hepatitis 0 9 580 589 B-chronic_disease
B 10 11 590 591 I-chronic_disease
or 12 14 592 594 O
Hepatitis 15 24 595 604 B-chronic_disease
C 25 26 605 606 I-chronic_disease
Uncontrolled 27 39 607 619 O
hypertension 40 52 620 632 B-chronic_disease

Histologic 0 10 633 643 O
diagnosis 11 20 644 653 O
of 21 23 654 656 O
glioblastoma 24 36 657 669 B-cancer
or 37 39 670 672 O
gliosarcoma 40 51 673 684 B-cancer
( 52 53 685 686 I-cancer
WHO 53 56 686 689 I-cancer
Grade 57 62 690 695 I-cancer
IV 63 65 696 698 I-cancer
) 65 66 698 699 I-cancer

History 0 7 700 707 O
of 8 10 708 710 O
abdominal 11 20 711 720 B-chronic_disease
fistula 21 28 721 728 I-chronic_disease
, 28 29 728 729 O
gastrointestinal 30 46 730 746 B-chronic_disease
perforation 47 58 747 758 I-chronic_disease
, 58 59 758 759 O
or 60 62 760 762 O
intra 63 68 763 768 B-chronic_disease
- 68 69 768 769 I-chronic_disease
abdominal 69 78 769 778 I-chronic_disease
abscess 79 86 779 786 I-chronic_disease
within 87 93 787 793 O
6 94 95 794 795 B-upper_bound
months 96 102 796 802 I-upper_bound
prior 103 108 803 808 I-upper_bound
to 109 111 809 811 O
Day 112 115 812 815 O
1 116 117 816 817 O

History 0 7 818 825 O
of 8 10 826 828 O
any 11 14 829 832 O
malignancy 15 25 833 843 B-cancer
( 26 27 844 845 O
other 27 32 845 850 O
than 33 37 851 855 O
glioblastoma 38 50 856 868 B-cancer
) 50 51 868 869 O
during 52 58 870 876 O
the 59 62 877 880 O
last 63 67 881 885 B-upper_bound
three 68 73 886 891 I-upper_bound
years 74 79 892 897 I-upper_bound
except 80 86 898 904 O
non 87 90 905 908 B-cancer
- 90 91 908 909 I-cancer
melanoma 91 99 909 917 I-cancer
skin 100 104 918 922 I-cancer
cancer 105 111 923 929 I-cancer
, 111 112 929 930 O
in 113 115 931 933 B-cancer
situ 116 120 934 938 I-cancer
cervical 121 129 939 947 I-cancer
cancer 130 136 948 954 I-cancer
, 136 137 954 955 O
treated 138 145 956 963 O
superficial 146 157 964 975 B-cancer
bladder 158 165 976 983 I-cancer
cancer 166 172 984 990 I-cancer
or 173 175 991 993 O
cured 176 181 994 999 O
, 181 182 999 1000 O
early 183 188 1001 1006 B-cancer
- 188 189 1006 1007 I-cancer
stage 189 194 1007 1012 I-cancer
prostate 195 203 1013 1021 I-cancer
cancer 204 210 1022 1028 I-cancer
in 211 213 1029 1031 O
a 214 215 1032 1033 O
patient 216 223 1034 1041 O
with 224 228 1042 1046 O
Prostate 229 237 1047 1055 B-clinical_variable
Surface 238 245 1056 1063 I-clinical_variable
Antigen 246 253 1064 1071 I-clinical_variable
( 254 255 1072 1073 I-clinical_variable
PSA 255 258 1073 1076 I-clinical_variable
) 258 259 1076 1077 I-clinical_variable
level 260 265 1078 1083 I-clinical_variable
< 266 267 1084 1085 O
ULN 267 270 1085 1088 O

History 0 7 1089 1096 O
, 7 8 1096 1097 O
presence 9 17 1098 1106 O
, 17 18 1106 1107 O
or 19 21 1108 1110 O
suspicion 22 31 1111 1120 O
of 32 34 1121 1123 O
metastatic 35 45 1124 1134 B-cancer
disease 46 53 1135 1142 I-cancer

Karnofsky 0 9 1143 1152 B-clinical_variable
performance 10 21 1153 1164 I-clinical_variable
status 22 28 1165 1171 I-clinical_variable
( 29 30 1172 1173 I-clinical_variable
KPS 30 33 1173 1176 I-clinical_variable
) 33 34 1176 1177 I-clinical_variable
of 35 37 1178 1180 O
≥ 38 39 1181 1182 O
70 40 42 1183 1185 B-lower_bound
% 42 43 1185 1186 I-lower_bound

Known 0 5 1187 1192 O
contraindication 6 22 1193 1209 O
or 23 25 1210 1212 O
hypersensitivity 26 42 1213 1229 O
to 43 45 1230 1232 O
any 46 49 1233 1236 O
component 50 59 1237 1246 O
of 60 62 1247 1249 O
bevacizumab 63 74 1250 1261 B-allergy_name

Life 0 4 1262 1266 B-clinical_variable
expectancy 5 15 1267 1277 I-clinical_variable
> 16 17 1278 1279 O
12 18 20 1280 1282 B-lower_bound
weeks 21 26 1283 1288 I-lower_bound

MRI 0 3 1289 1292 O
record 4 10 1293 1299 O
must 11 15 1300 1304 O
be 16 18 1305 1307 O
obtained 19 27 1308 1316 O
showing 28 35 1317 1324 O
the 36 39 1325 1328 O
MRI 40 43 1329 1332 O
was 44 47 1333 1336 O
conducted 48 57 1337 1346 O
at 58 60 1347 1349 O
least 61 66 1350 1355 O
4 67 68 1356 1357 B-lower_bound
weeks 69 74 1358 1363 I-lower_bound
after 75 80 1364 1369 O
any 81 84 1370 1373 O
salvage 85 92 1374 1381 B-treatment
surgery 93 100 1382 1389 I-treatment
, 100 101 1389 1390 O
and 102 105 1391 1394 O
at 106 108 1395 1397 O
least 109 114 1398 1403 O
12 115 117 1404 1406 B-lower_bound
weeks 118 123 1407 1412 I-lower_bound
after 124 129 1413 1418 O
radiation 130 139 1419 1428 B-treatment
therapy 140 147 1429 1436 I-treatment
, 147 148 1436 1437 O
or 149 151 1438 1440 O
at 152 154 1441 1443 O
least 155 160 1444 1449 O
4 161 162 1450 1451 O
weeks 163 168 1452 1457 O
after 169 174 1458 1463 O
radiation 175 184 1464 1473 O
for 185 188 1474 1477 O
a 189 190 1478 1479 O
new 191 194 1480 1483 O
lesion 195 201 1484 1490 O
outside 202 209 1491 1498 O
the 210 213 1499 1502 O
prior 214 219 1503 1508 B-treatment
primary 220 227 1509 1516 I-treatment
radiation 228 237 1517 1526 I-treatment
field 238 243 1527 1532 I-treatment

Men 0 3 1533 1536 B-gender
refusing 4 12 1537 1545 O
to 13 15 1546 1548 O
exercise 16 24 1549 1557 O
a 25 26 1558 1559 O
reliable 27 35 1560 1568 O
form 36 40 1569 1573 O
of 41 43 1574 1576 O
contraception 44 57 1577 1590 O

Patients 0 8 1591 1599 O
must 9 13 1600 1604 O
have 14 18 1605 1609 O
histologically 19 33 1610 1624 O
confirmed 34 43 1625 1634 O
diagnosis 44 53 1635 1644 O
of 54 56 1645 1647 O
a 57 58 1648 1649 O
recurrent 59 68 1650 1659 O
/ 68 69 1659 1660 O
progressive 69 80 1660 1671 O
WHO 81 84 1672 1675 O
grade 85 90 1676 1681 B-cancer
IV 91 93 1682 1684 I-cancer
malignant 94 103 1685 1694 I-cancer
gliomas 104 111 1695 1702 I-cancer
( 112 113 1703 1704 O
glioblastoma 113 125 1704 1716 B-cancer
multiforme 126 136 1717 1727 I-cancer
and 137 140 1728 1731 O
gliosarcoma 141 152 1732 1743 B-cancer
) 152 153 1743 1744 O

Patients 0 8 1745 1753 O
taking 9 15 1754 1760 O
temozolomide 16 28 1761 1773 B-treatment
can 29 32 1774 1777 O
start 33 38 1778 1783 O
study 39 44 1784 1789 O
treatment 45 54 1790 1799 B-treatment
23 55 57 1800 1802 O
days 58 62 1803 1807 O
from 63 67 1808 1812 O
the 68 71 1813 1816 O
last 72 76 1817 1821 O
temozolamide 77 89 1822 1834 B-treatment
dose 90 94 1835 1839 O
. 94 95 1839 1840 O
For 96 99 1841 1844 O
all 100 103 1845 1848 O
other 104 109 1849 1854 O
chemotherapy 110 122 1855 1867 B-treatment
drugs 123 128 1868 1873 O
, 128 129 1873 1874 O
study 130 135 1875 1880 O
treatment 136 145 1881 1890 O
can 146 149 1891 1894 O
start 150 155 1895 1900 O
as 156 158 1901 1903 O
long 159 163 1904 1908 O
as 164 166 1909 1911 O
adverse 167 174 1912 1919 O
events 175 181 1920 1926 O
related 182 189 1927 1934 O
to 190 192 1935 1937 O
their 193 198 1938 1943 O
treatment 199 208 1944 1953 O
is 209 211 1954 1956 O
< 212 213 1957 1958 O
/= 213 215 1958 1960 O
to 216 218 1961 1963 O
Grade 219 224 1964 1969 B-upper_bound
1 225 226 1970 1971 I-upper_bound

Presence 0 8 1972 1980 O
of 9 11 1981 1983 O
diffuse 12 19 1984 1991 O
leptomeningeal 20 34 1992 2006 B-chronic_disease
disease 35 42 2007 2014 I-chronic_disease

Previous 0 8 2015 2023 B-treatment
treatment 9 18 2024 2033 I-treatment
for 19 22 2034 2037 O
glioblastoma 23 35 2038 2050 B-cancer
must 36 40 2051 2055 O
include 41 48 2056 2063 O
surgery 49 56 2064 2071 B-treatment
( 57 58 2072 2073 O
biopsy 58 64 2073 2079 B-treatment
, 64 65 2079 2080 O
partial 66 73 2081 2088 B-treatment
resection 74 83 2089 2098 I-treatment
, 83 84 2098 2099 O
or 85 87 2100 2102 O
full 88 92 2103 2107 B-treatment
surgical 93 101 2108 2116 I-treatment
resection 102 111 2117 2126 I-treatment
) 111 112 2126 2127 O
, 112 113 2127 2128 O
conventional 114 126 2129 2141 B-treatment
radiation 127 136 2142 2151 I-treatment
therapy 137 144 2152 2159 I-treatment
and 145 148 2160 2163 O
temozolomide 149 161 2164 2176 B-treatment
( 162 163 2177 2178 I-treatment
TMZ 163 166 2178 2181 I-treatment
) 166 167 2181 2182 I-treatment

Prior 0 5 2183 2188 O
receipt 6 13 2189 2196 O
of 14 16 2197 2199 O
bevacizumab 17 28 2200 2211 B-treatment
or 29 31 2212 2214 O
other 32 37 2215 2220 O
VEGF- 38 43 2221 2226 B-treatment
or 44 46 2227 2229 O
VEGF 47 51 2230 2234 B-treatment
receptor 52 60 2235 2243 I-treatment
- 60 61 2243 2244 I-treatment
targeted 61 69 2244 2252 I-treatment
agents 70 76 2253 2259 I-treatment

Resolution 0 10 2260 2270 O
of 11 13 2271 2273 O
all 14 17 2274 2277 O
chemotherapy 18 30 2278 2290 B-treatment
or 31 33 2291 2293 O
radiation 34 43 2294 2303 B-treatment
- 43 44 2303 2304 O
related 44 51 2304 2311 O
toxicities 52 62 2312 2322 O
≤ 63 64 2323 2324 O
CTCAE 65 70 2325 2330 O
Grade 71 76 2331 2336 B-upper_bound
1 77 78 2337 2338 I-upper_bound
severity 79 87 2339 2347 O
, 87 88 2347 2348 O
except 89 95 2349 2355 O
for 96 99 2356 2359 O
alopecia 100 108 2360 2368 B-chronic_disease
and 109 112 2369 2372 O
hematologic 113 124 2373 2384 O
toxicity 125 133 2385 2393 O

Stroke 0 6 2394 2400 B-chronic_disease
, 6 7 2400 2401 O
transient 8 17 2402 2411 B-chronic_disease
ischemic 18 26 2412 2420 I-chronic_disease
attack 27 33 2421 2427 I-chronic_disease
, 33 34 2427 2428 O
unstable 35 43 2429 2437 B-chronic_disease
angina 44 50 2438 2444 I-chronic_disease
, 50 51 2444 2445 O
myocardial 52 62 2446 2456 B-chronic_disease
infarction 63 73 2457 2467 I-chronic_disease
or 74 76 2468 2470 O
congestive 77 87 2471 2481 B-chronic_disease
heart 88 93 2482 2487 I-chronic_disease
failure 94 101 2488 2495 I-chronic_disease
( 102 103 2496 2497 O
New 103 106 2497 2500 B-clinical_variable
York 107 111 2501 2505 I-clinical_variable
Heart 112 117 2506 2511 I-clinical_variable
Association 118 129 2512 2523 I-clinical_variable
Grade 130 135 2524 2529 B-lower_bound
II 136 138 2530 2532 I-lower_bound
or 139 141 2533 2535 O
greater 142 149 2536 2543 O
) 149 150 2543 2544 O
within 151 157 2545 2551 O
the 158 161 2552 2555 O
past 162 166 2556 2560 B-upper_bound
12 167 169 2561 2563 I-upper_bound
months 170 176 2564 2570 I-upper_bound

Subjects 0 8 2571 2579 O
with 9 13 2580 2584 O
any 14 17 2585 2588 O
known 18 23 2589 2594 O
uncontrolled 24 36 2595 2607 O
inter 37 42 2608 2613 O
- 42 43 2613 2614 O
current 43 50 2614 2621 O
illness 51 58 2622 2629 O
including 59 68 2630 2639 O
ongoing 69 76 2640 2647 O
or 77 79 2648 2650 O
active 80 86 2651 2657 B-chronic_disease
infection 87 96 2658 2667 I-chronic_disease
, 96 97 2667 2668 O
symptomatic 98 109 2669 2680 O
congestive 110 120 2681 2691 B-chronic_disease
heart 121 126 2692 2697 I-chronic_disease
failure 127 134 2698 2705 I-chronic_disease
( 135 136 2706 2707 O
NYHA 136 140 2707 2711 B-clinical_variable
Gr.2 141 145 2712 2716 B-lower_bound
or 146 148 2717 2719 O
> 149 150 2720 2721 O
) 150 151 2721 2722 O
, 151 152 2722 2723 O
myocardial 153 163 2724 2734 B-chronic_disease
infarction 164 174 2735 2745 I-chronic_disease
, 174 175 2745 2746 O
unstable 176 184 2747 2755 B-chronic_disease
angina 185 191 2756 2762 I-chronic_disease
pectoris 192 200 2763 2771 I-chronic_disease
, 200 201 2771 2772 O
within 202 208 2773 2779 O
the 209 212 2780 2783 O
past 213 217 2784 2788 B-upper_bound
12 218 220 2789 2791 I-upper_bound
months 221 227 2792 2798 I-upper_bound

Systemic 0 8 2799 2807 B-treatment
corticosteroid 9 23 2808 2822 I-treatment
therapy 24 31 2823 2830 I-treatment
must 32 36 2831 2835 O
be 37 39 2836 2838 O
at 40 42 2839 2841 O
a 43 44 2842 2843 O
dose 45 49 2844 2848 O
of 50 52 2849 2851 O
≤ 53 54 2852 2853 O
4 55 56 2854 2855 B-upper_bound
mg 57 59 2856 2858 I-upper_bound
of 60 62 2859 2861 O
dexamethasone 63 76 2862 2875 B-treatment
or 77 79 2876 2878 O
equivalent 80 90 2879 2889 O
per 91 94 2890 2893 O
day 95 98 2894 2897 O
during 99 105 2898 2904 O
the 106 109 2905 2908 O
week 110 114 2909 2913 O
prior 115 120 2914 2919 O
to 121 123 2920 2922 O
Day 124 127 2923 2926 O
1 128 129 2927 2928 O

Unstable 0 8 2929 2937 O
or 9 11 2938 2940 O
severe 12 18 2941 2947 O
inter 19 24 2948 2953 O
- 24 25 2953 2954 O
current 25 32 2954 2961 O
medical 33 40 2962 2969 O
conditions 41 51 2970 2980 O
chronic 52 59 2981 2988 B-chronic_disease
renal 60 65 2989 2994 I-chronic_disease
disease 66 73 2995 3002 I-chronic_disease
, 73 74 3002 3003 O
or 75 77 3004 3006 O
uncontrolled 78 90 3007 3019 O
diabetes 91 99 3020 3028 B-chronic_disease
mellitus 100 108 3029 3037 I-chronic_disease

Urine 0 5 3038 3043 O
protein 6 13 3044 3051 O
: 13 14 3051 3052 O
creatinine 15 25 3053 3063 B-clinical_variable
ratio 26 31 3064 3069 I-clinical_variable
≥ 32 33 3070 3071 O
1.0 34 37 3072 3075 B-lower_bound
at 38 40 3076 3078 O
screening 41 50 3079 3088 O

Women 0 5 3089 3094 B-gender
who 6 9 3095 3098 O
are 10 13 3099 3102 B-pregnancy
pregnant 14 22 3103 3111 I-pregnancy
or 23 25 3112 3114 O
lactating 26 35 3115 3124 O

absolute 0 8 3125 3133 B-clinical_variable
neutrophil 9 19 3134 3144 I-clinical_variable
count>1,000 20 31 3145 3156 I-clinical_variable
/ 31 32 3156 3157 I-lower_bound
mcL 32 35 3157 3160 I-lower_bound

aspartate 0 9 3161 3170 B-clinical_variable
aminotransferase 10 26 3171 3187 I-clinical_variable
( 27 28 3188 3189 I-clinical_variable
AST)(SGOT)/ 28 39 3189 3200 I-clinical_variable
Alanine 40 47 3201 3208 B-clinical_variable
aminotransferase(ALT)(SGPT)<2.5 48 79 3209 3240 I-clinical_variable
X 80 81 3241 3242 I-upper_bound
institutional 82 95 3243 3256 I-upper_bound
upper 96 101 3257 3262 I-upper_bound
limit 102 107 3263 3268 I-upper_bound
of 108 110 3269 3271 I-upper_bound
normal 111 117 3272 3278 I-upper_bound

blood 0 5 3279 3284 B-clinical_variable
pressure 6 14 3285 3293 I-clinical_variable
of 15 17 3294 3296 O
> 18 19 3297 3298 O
150 20 23 3299 3302 B-lower_bound
mmHg 24 28 3303 3307 I-lower_bound
systolic 29 37 3308 3316 B-clinical_variable
and 38 41 3317 3320 O
> 42 43 3321 3322 O
100 44 47 3323 3326 B-lower_bound
mmHg 48 52 3327 3331 I-lower_bound
diastolic 53 62 3332 3341 B-clinical_variable
, 62 63 3341 3342 O
or 64 66 3343 3345 O
history 67 74 3346 3353 O
of 75 77 3354 3356 O
hypertensive 78 90 3357 3369 O
encephalopathy 91 105 3370 3384 B-chronic_disease

bone 0 4 3385 3389 B-chronic_disease
fracture 5 13 3390 3398 I-chronic_disease

hemoglobin 0 10 3399 3409 B-clinical_variable
( 11 12 3410 3411 I-clinical_variable
Hbg 12 15 3411 3414 I-clinical_variable
) 15 16 3414 3415 I-clinical_variable
> 17 18 3416 3417 O
9g 19 21 3418 3420 B-lower_bound
/ 21 22 3420 3421 I-lower_bound
dL 22 24 3421 3423 I-lower_bound

human 0 5 3424 3429 B-chronic_disease
immunodeficiency 6 22 3430 3446 I-chronic_disease
virus 23 28 3447 3452 I-chronic_disease
( 29 30 3453 3454 I-chronic_disease
HIV 30 33 3454 3457 I-chronic_disease
) 33 34 3457 3458 I-chronic_disease
infection 35 44 3459 3468 I-chronic_disease

leukocytes 0 10 3469 3479 B-clinical_variable
> 11 12 3480 3481 O
1,500 12 17 3481 3486 B-lower_bound
/ 17 18 3486 3487 I-lower_bound
microliter 18 28 3487 3497 I-lower_bound
( 29 30 3498 3499 I-lower_bound
mcL 30 33 3499 3502 I-lower_bound
) 33 34 3502 3503 I-lower_bound

platelets>125,000 0 17 3504 3521 B-clinical_variable
/ 17 18 3521 3522 I-lower_bound
mcL 18 21 3522 3525 I-lower_bound

presence 0 8 3526 3534 O
of 9 11 3535 3537 O
hemosiderin 12 23 3538 3549 B-clinical_variable

presence 0 8 3550 3558 O
of 9 11 3559 3561 O
punctate 12 20 3562 3570 B-cancer
hemorrhage 21 31 3571 3581 I-cancer
in 32 34 3582 3584 I-cancer
the 35 38 3585 3588 I-cancer
tumor 39 44 3589 3594 I-cancer

resolving 0 9 3595 3604 O
hemorrhagic 10 21 3605 3616 O
changes 22 29 3617 3624 O
related 30 37 3625 3632 O
to 38 40 3633 3635 O
surgery 41 48 3636 3643 B-treatment

serum 0 5 3644 3649 B-clinical_variable
creatinine 6 16 3650 3660 I-clinical_variable
< 17 18 3661 3662 O
1.5 19 22 3663 3666 B-upper_bound
mg 23 25 3667 3669 I-upper_bound
/ 25 26 3669 3670 I-upper_bound
dl 26 28 3670 3672 I-upper_bound

total 0 5 3673 3678 B-clinical_variable
bilirubin 6 15 3679 3688 I-clinical_variable
within 16 22 3689 3695 O
normal 23 29 3696 3702 O
institutional 30 43 3703 3716 O
limits 44 50 3717 3723 O

ulcer 0 5 3724 3729 B-chronic_disease

